Expertises
Therapeutics
Delivery Of Health Care
Breast Neoplasms
Health
Costs And Cost Analysis
Decision Making
Cost-Benefit Analysis
Surveys And Questionnaires
Verbonden aan
Nevenactiviteiten
-
NMS ventures bv
Advieswerkzaamheden -
Radiotherapiegroep
Lid Raad van Toezicht -
Stichting int health techn services
Bestuur stichting -
Maxima Medisch Centrum, Veldhoven
Lid Raad van Toezicht
Publicaties
Recent
Kip, M. M. A., IJzerman, M. J., Henriksson, M., Merlin, T., Weinstein, M. C., Phelps, C. E., ... Koffijberg, H. (2018). Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist. Medical decision making, 38(7), 778-788. DOI: 10.1177/0272989X18797590
Wong, X. Y., Groothuis-Oudshoorn, C. G. M., Tan, C. S., van Til, J. A., Hartman, M., Chong, K. J., ... Wee, H-L. (2018). Women's preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment. Patient Preference and Adherence, 12, 1837-1852. DOI: 10.2147/PPA.S171348
Witteveen, A., Otten, J. W. M., Vliegen, I. M. H., Siesling, S., Timmer, J. B., & IJzerman, M. J. (2018). Risk-based breast cancer follow-up stratified by age. Cancer medicine, 1. [CAM41760]. DOI: 10.1002/cam4.1760
Weernink, M. G. M., Vaanholt, M. C. W., Groothuis-Oudshoorn, C. G. M., von Birgelen, C., IJzerman, M. J., & van Til, J. A. (2018). Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis. American Journal of Cardiovascular Drugs. DOI: 10.1007/s40256-018-0293-0
Witteveen, A., Nane, G. F., Vliegen, I. M. H., Siesling, S., & IJzerman, M. J. (2018). Comparison of Logistic Regression and Bayesian Networks for Risk Prediction of Breast Cancer Recurrence. Medical decision making, 38(7), 822-833. DOI: 10.1177/0272989X18790963
IJzerman, M. J., Berghuis, A. M., de Bono, J. S., & Terstappen, L. W. M. M. (2018). Health economic impact of liquid biopsies in cancer management. Expert review of pharmacoeconomics & outcomes research, 1-7. DOI: 10.1080/14737167.2018.1505505
Kok, M. M., von Birgelen, C., Sattar, N., Zocca, P., Löwik, M. M., Danse, P. W., ... van der Heijden, L. C. (2018). Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population. EuroIntervention. DOI: 10.4244/EIJ-D-17-01067
Crown, W., Buyukkaramikli, N., Sir, M. Y., Thokala, P., Morton, A., Marshall, D. A., ... Pasupathy, K. S. (2018). Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force. Value in health. DOI: 10.1016/j.jval.2018.05.003
Vaanholt, M. C. W., Weernink, M. G. M., von Birgelen, C., Groothuis-Oudshoorn, C. G. M., IJzerman, M. J., & van Til, J. A. (2018). Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen. Patient education and counseling. DOI: 10.1016/j.pec.2018.06.019
Berghuis, A. M. S., Koffijberg, H., Terstappen, L. W. M. M., Sleijfer, S., & IJzerman, M. J. (2018). Evidence on the cost of breast cancer drugs is required for rational decision making. Ecancermedicalscience, 12, [825]. DOI: 10.3332/ecancer.2018.825
Pure Link
Google Scholar Link
Verbonden aan Opleidingen
Master
Contactgegevens
Bezoekadres
Universiteit Twente
Drienerlolaan 5
7522 NB Enschede
Postadres
Universiteit Twente
Postbus 217
7500 AE Enschede